comorbidities

Guo L, Bilimoria SN, Kikuchi R, Hao A, Sadrolashrafi K, Yamamoto RK, Tolson H, Yee D, Armstrong AW. Chronic Obstructive Pulmonary Disease Outcomes in Psoriasis[...]

By sjmartinez • November 14, 2024

Peterson H, Huang MY, Lee K, Kingston P, Yee D, Korouri E, Agüero R, Armstrong AW. Comorbidity Burden in Psoriasis Patients with Skin of Color.[...]

By sjmartinez • March 22, 2024

Varma N, Han JK, Passman R, Rosman LA, Ghanbari H, Noseworthy P, Avari Silva JN, Deshmukh A, Sanders P, Hindricks G, Lip G, Sridhar AR.[...]

By sjmartinez • February 1, 2024

Shover CL, Friedman JR, Romero R, Buhr R, Chu B, Tang A, Medina JA, Wisk L, Lucas J, Goodman-Meza D. Longitudinal changes in co-involved drugs,[...]

By sjmartinez • June 15, 2023

Broglie L, Friend BD, Chhabra S, Logan BR, Bupp C, Schiller G, Savani BN, Stadtmauer E, Abraham AA, Aljurf M, Badawy SM, Perez MAD, Guinan[...]

By sjmartinez • February 14, 2023

Friend BD, Broglie L, Logan BR, Chhabra S, Bupp C, Schiller G, Beitinjaneh A, Perez MAD, Guilcher GMT, Hashem H, Hildebrandt GC, Krem MM, Lazarus[...]

By sjmartinez • February 14, 2023

Schaenman J, Byford H, Grogan T, Motwani Y, Beaird OE, Kamath M, Lum E, Meneses K, Sayah D, Vucicevic D, Saab S. Impact of solid[...]

By sjmartinez • August 31, 2022

Padwa H, Huang D, Mooney L, Grella CE, Urada D, Bell DS, Bass B, Boustead AE. Medical conditions of primary care patients with documented cannabis[...]

By rosaguerrero • May 9, 2022